Contract Manufacturing, Finished Drug Product

Catalent Expands Fill-Finish Capacity

January 08, 2020

Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy

Catalent to Supply BeiGene’s Brukinsa

November 25, 2019

The companies announced a commercial supply agreement following FDA’s accelerated approval.

Thermo Fisher Scientific Expands Capabilities

November 22, 2019

New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.

Particle Sciences Rebrands as Lubrizol Life Science Health

November 22, 2019

Lubrizol Life Science Health adopts new name and opens commercial manufacturing facility.

Taiwanese CDMO Gains FDA Approval for Zhunan Facility

September 13, 2019

Bora Pharmaceuticals has announced it has achieved success in the latest FDA general inspection of its Zhunan facility with zero 483 observations.

Partnering Up for Success

August 02, 2019

Pharmaceutical Technology Europe

To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.

HPAPI Capacity Challenges

August 01, 2019

Does the pharmaceutical industry have adequate access to contained equipment, facilities, and infrastructure for the manufacture of highly potent APIs?

Catalent Breaks Ground at $112-Million Drug Product Manufacturing Facility

July 17, 2019

Catalent recently held a groundbreaking ceremony at its Bloomington, Indiana pharmaceutical fill/finish site.

LSNE Expands to Europe with Acquisition of Facility in Spain

June 19, 2019

Lyophilization Services of New England acquired a sterile injectables manufacturing facility in León, Spain.

Tergus Pharma Plans Commercial Manufacturing Facility

June 07, 2019

Tergus Pharma announced a partnership with Great Point Partners and construction of a new commercial manufacturing facility in North Carolina.